Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02385799 · ClinicalTrials.gov registry record · Phase 2

A Trial of Sertraline in Young Children With Autism Spectrum Disorder

A Phase 2 study of Autism Spectrum Disorder, sponsored by Randi J. Hagerman, MD.

Completed
Registry status
Phase 2
Development phase
58
Enrollment target
1
Study location

NCT02385799 is a Phase 2 study of Autism Spectrum Disorder that has completed, run by Randi J. Hagerman, MD. The registered enrollment target is 58 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02385799, a Phase 2 study of Autism Spectrum Disorder, has completed, sponsored by Randi J. Hagerman, MD.

COMPLETED
Registry status
Phase 2
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

This study is a control trial of sertraline (Zoloft) in children aged 2 to 5 years old inclusive with Autism Spectrum Disorder. The trial is six months long, and each participant will receive a series of tests at both the beginning and end of the study. The researchers hope to show improvements in language and social deficits.

Conditions Studied

Autism Spectrum Disorder

Interventions

  • DRUG Sertraline
  • DRUG Sertraline Liquid Placebo

Study Locations (1)

California

  • UC Davis MIND Institute - Sacramento

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2015-04
Est. Completion 2018-07
Phase Phase 2

Sponsor

Randi J. Hagerman, MD

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02385799

The ClinicalTrials.gov registry entry for NCT02385799 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (57% lower). The listed sponsor is Randi J. Hagerman, MD, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sertraline is the first listed.

NCT02385799 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02385799 about?

NCT02385799 is a clinical study titled "A Trial of Sertraline in Young Children With Autism Spectrum Disorder". This study is a control trial of sertraline (Zoloft) in children aged 2 to 5 years old inclusive with Autism Spectrum Disorder. The trial is six months long, and each participant will receive a series of tests at both the beginning and end of the study. The researchers hope to show improvements in l...

What is the current status of trial NCT02385799?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 58 participants. The study started on 2015-04. Estimated completion is 2018-07.

What conditions does trial NCT02385799 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT02385799?

The interventions under investigation include: Sertraline (DRUG), Sertraline Liquid Placebo (DRUG).

Who is sponsoring clinical trial NCT02385799?

This trial is sponsored by Randi J. Hagerman, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02385799 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.